Therapeutic Product Detail

Atosiban

Explore technical data, documentation access, molecular information and enquiry options for this Clearsynth research product.

Product Code: CS-O-00863 Therapeutic Research Use Only
Atosiban
Category
Therapeutic
API Family
Atosiban
Product Code
CS-O-00863
Research Status
For Laboratory Use

Atosiban

Atosiban Therapeutic
Stock Status: In Stock
Live

CAT No.
CS-O-00863
CAS No.
90779-69-4
Molecular Formula
C₄₃H₆₇N₁₁O₁₂S₂
Molecular Weight
994.19
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal or Veterinary use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
90779-69-4
Product Code
CS-O-00863
M.F.
C₄₃H₆₇N₁₁O₁₂S₂
M.W.
994.19
Smiles
O=C([C@H]1NC([C@@H](NC([C@](NC([C@](NC([C@H](NC(CCSSC1)=O)CC2=CC=C(C=C2)OCC)=O)([H])[C@@H](C)CC)=O)([H])[C@H](O)C)=O)CC(N)=O)=O)N3[C@@H](CCC3)C(N[C@@H](CCCN)C(NCC(N)=O)=O)=O
Category
Therapeutic
API Family
Atosiban
Storage Condition
Store at freezer (-20°C) for long term storage
IUPAC Name
(S)-N-((S)-5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide
References
"Simsek; Y,; et al,: Ach, Gyncol, Obstet,; 286; 777 (2012); Mak; P,; et al,: J, Pschopharmcol,; 26; 532 (2012); Simsek; Y,; et al,: Ach, Gyncol, Obstet,; 285; 655 (2012);"
Synonyms
Not available'
Application Notes
Atosiban is an oxytocin receptor blocking agent in the treatment of experimental endometriosis and was shown exhibit significant therapeutic efficiency.
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Overview
Atosiban is an oxytocin receptor blocking agent in the treatment of experimental endometriosis and was shown exhibit significant therapeutic efficiency.

Refund Policy

We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of material handover. We have invested in the highest quality packaging materials and use international logistics partners to service our customers. If there is an issue with one or more of our products, it must be reported to us within 45 days of your receiving shipment for refund or account credit eligibility.

Downloading MSDS…
Quick Enquiry Email Us
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.